| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217100 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 9 Pages |
Abstract
For limited disease, response-adaptive therapy demonstrated comparable outcomes with RT alone. Rituximab monotherapy resulted in inferior outcomes for limited disease and a high relapse rate for advanced disease.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Martin T. MD, PhD, Sarah S. MD, Michael P. MD, Yasodha MD, PhD, Ranjana H. MD, Richard T. MD,